FTXH

First Trust Nasdaq Pharmaceuticals ETF

Up$20.08
+$0.04
(+0.22%)
As of 6:55:00 PM EDT | 4/18/19  |  Market Closed

FTXH Trading Data

Open

$20.18

Low Price

$19.85

High Price

$20.18

Previous Last Price

$20.04

Bid Size

$0 X 0

Ask Size

$0 X 0

FTXH Portfolio Data

AUM

$5,032,500

Shares

250

PE Ratio

26.07

Price / Book Ratio

3.51

Expense Ratio

0.6

Net Asset Value

$20.13

Volume

Volume

2,400

Avg. Volume (YDT)

2,294

Dollar Volume

$40,238

Weekly Avg. Volume

5,760

Monthly Avg. Volume

2,545

Quarterly Avg. Volume

2,430

FTXH Fund Description

The First Trust Nasdaq Pharmaceuticals ETF is an exchange-traded fund. The investment objective of the Fund is to seek investment results that correspond generally to the price and yield, before the Fund's fees and expenses, of an index called the Nasdaq US Smart Pharmaceuticals Index. The Fund seeks to replicate the holdings and weightings of the Nasdaq US Smart Pharmaceuticals Index so as to generate performance results 95% correlated to that of the Nasdaq US Smart Pharmaceuticals Index.

FTXH Chart

FTXH Summary

Fund Family

First Trust Portfolios

Tracks This Index

First Trust Nasdaq Pharmaceuticals ETF

Inception Date

2016-09-20

Asset Class

Equity

Asset Class Size

Large Cap

FTXH Classification

Region (General)

North America

Region (Specific)

US

Sector

Equity Index

Leveraged Family

FTXH Holdings

Top 10 Holdings

Abbott Laboratories (ABT)
8.15%
Eli Lilly and Company (LLY)
8%
Pfizer Inc. (PFE)
7.98%
Merck & Co. Inc. (MRK)
7.89%
Horizon Pharma Plc (HZNP)
7.36%
Zoetis Inc. (ZTS)
4.51%
Allergan Plc (AGN)
4.41%
Johnson & Johnson (JNJ)
4.4%
Catalent Inc. (CTLT)
4.29%
Jazz Pharmaceuticals Plc (JAZZ)
3.96%

Total FTXH Holdings

Total Holdings: 31

Abbott Laboratories (ABT)
8.15%
Eli Lilly and Company (LLY)
8%
Pfizer Inc. (PFE)
7.98%
Merck & Co. Inc. (MRK)
7.89%
Horizon Pharma Plc (HZNP)
7.36%
Zoetis Inc. (ZTS)
4.51%
Allergan Plc (AGN)
4.41%
Johnson & Johnson (JNJ)
4.4%
Catalent Inc. (CTLT)
4.29%
Jazz Pharmaceuticals Plc (JAZZ)
3.96%
Bristol-Myers Squibb Company (BMY)
3.85%
Innoviva Inc. (INVA)
3.69%
The Medicines Company (MDCO)
2.15%
Amicus Therapeutics Inc. (FOLD)
2.05%
Perrigo Company Plc (PRGO)
1.97%
Mylan N.V. (MYL)
1.95%
Sage Therapeutics Inc. (SAGE)
1.95%
Alkermes Plc (ALKS)
1.92%
AbbVie Inc. (ABBV)
1.9%
Corcept Therapeutics Incorporated (CORT)
1.84%
Blueprint Medicines Corporation (BPMC)
1.73%
Pacira BioSciences Inc. (PCRX)
1.71%
Esperion Therapeutics Inc. (ESPR)
1.68%
Heron Therapeutics Inc. (HRTX)
1.66%
Supernus Pharmaceuticals Inc. (SUPN)
1.66%
Vanda Pharmaceuticals Inc. (VNDA)
1.59%
Madrigal Pharmaceuticals Inc. (MDGL)
1.56%
Ironwood Pharmaceuticals Inc. (IRWD)
1.51%
Zogenix Inc. (ZGNX)
1.33%
Endo International Plc (ENDP)
1.25%
First Trust Nasdaq Pharmaceuticals ETF (FTXH)
0%

FTXH Technicals

Alpha

0

Beta

1.13

Leverage

Long

Standard Deviation

1.2

FTXH Dividends

Dividend Date

2019-03-21

Latest Dividend

0.026

Annual Dividend

0.12

Annual Dividend Rate

0.12

Annual Dividend Yield

0.62

FTXH Performance

YTD Return

4.55%

1 Year Return

-6.06%

3 Year Return

0%

5 Year Return

0%

10 Year Return

1.85%

FTXH Related Articles